Cargando…

Myocardial global longitudinal strain: An early indicator of cardiac interstitial fibrosis modified by spironolactone, in a unique hypertensive rat model

OBJECTIVES: Is global longitudinal strain (GLS) a more accurate non-invasive measure of histological myocardial fibrosis than left ventricular ejection fraction (LVEF) in a hypertensive rodent model. BACKGROUND: Hypertension results in left ventricular hypertrophy and cardiac dysfunction. Speckle-tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leader, Catherine J., Moharram, Mohammed, Coffey, Sean, Sammut, Ivan A., Wilkins, Gerard W., Walker, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690508/ https://www.ncbi.nlm.nih.gov/pubmed/31404095 http://dx.doi.org/10.1371/journal.pone.0220837

Ejemplares similares

Spironolactone mitigates, but does not reverse, the progression of renal fibrosis in a transgenic hypertensive rat
por: Leader, Catherine J., et al.
Publicado: (2020)

The effect of spironolactone on cardiac and renal fibrosis following myocardial infarction in established hypertension in the transgenic Cyp1a1Ren2 rat
por: Leader, C. J., et al.
Publicado: (2021)

Cardiac Magnetic Resonance Assessment of Interstitial Myocardial Fibrosis and Cardiomyocyte Hypertrophy in Hypertensive Mice Treated With Spironolactone
por: Coelho‐Filho, Otavio R., et al.
Publicado: (2014)

Renal Fibrosis mRNA Classifier: Validation in Experimental Lithium-Induced Interstitial Fibrosis in the Rat Kidney
por: Marti, Hans-Peter, et al.
Publicado: (2016)

Spironolactone alleviates myocardial fibrosis via inhibition of Ets-1 in mice with experimental autoimmune myocarditis
por: Wang, Wen-Ke, et al.
Publicado: (2022)

Mechanisms Involved in the Beneficial Effects of Spironolactone after Myocardial Infarction
por: Minicucci, Marcos F., et al.
Publicado: (2013)

Treatment of myocardial interstitial fibrosis in pathological myocardial hypertrophy
por: Zhu, Fuyu, et al.
Publicado: (2022)

Effects of spironolactone and losartan on the early neovascularization of acute myocardial infarction
por: LIU, YAN, et al.
Publicado: (2014)

Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan
por: Makhlough, Atieh, et al.
Publicado: (2014)

Myocardial tissue characterisation using echocardiographic deformation imaging
por: Moharram, Mohammed A., et al.
Publicado: (2019)

Diffuse interstitial fibrosis in well-controlled hypertension
por: Treibel, Thomas A, et al.
Publicado: (2013)

Spironolactone in pulmonary arterial hypertension: results of a cross-over study
por: Safdar, Zeenat, et al.
Publicado: (2020)

Association of spironolactone treatment and arterial stiffness and cardiovascular disease in hypertensive patients
por: Zeng, Fanfang, et al.
Publicado: (2019)

Potential Reduction of Interstitial Myocardial Fibrosis With Renal Denervation
por: Doltra, Adelina, et al.
Publicado: (2014)

Effects of spironolactone in spontaneously hypertensive adult rats subjected to high salt intake
por: Baldo, Marcelo Perim, et al.
Publicado: (2011)

Spironolactone Lowers Portal Hypertension by Inhibiting Liver Fibrosis, ROCK-2 Activity and Activating NO/PKG Pathway in the Bile-Duct-Ligated Rat
por: Luo, Wei, et al.
Publicado: (2012)

Spironolactone Reduces Aortic Stiffness in Patients With Resistant Hypertension Independent of Blood Pressure Change
por: Aryal, Sudeep R., et al.
Publicado: (2021)

Spironolactone-Induced Unilateral Gynecomastia
por: Veeregowda, Sahana Hadihalli, et al.
Publicado: (2018)

Efficacy of mineralocorticoid receptor antagonism in the acute myocardial infarction phase: eplerenone versus spironolactone
por: Fraccarollo, Daniela, et al.
Publicado: (2015)

Periodontal Disease Associated With Interstitial Myocardial Fibrosis: The Multiethnic Study of Atherosclerosis
por: Doughan, Maria, et al.
Publicado: (2023)

Effect of spironolactone use in pulmonary arterial hypertension – analysis from pivotal trial databases
por: Safdar, Zeenat, et al.
Publicado: (2021)

Association between Use of Spironolactone and Risk of Stroke in Hypertensive Patients: A Cohort Study
por: Cai, Xintian, et al.
Publicado: (2022)

IMproved exercise tolerance in patients with PReserved Ejection fraction by Spironolactone on myocardial fibrosiS in Atrial Fibrillation rationale and design of the IMPRESS-AF randomised controlled trial
por: Shantsila, Eduard, et al.
Publicado: (2016)

Spironolactone Regulates HCN Protein Expression Through Micro-RNA-1 in Rats With Myocardial Infarction
por: Yu, Hua-Dong, et al.
Publicado: (2015)

Diffuse Myocardial Interstitial Fibrosis and Dysfunction in Early Chronic Kidney Disease
por: Hayer, Manvir Kaur, et al.
Publicado: (2018)

Effect of spironolactone on pain responses in mice
por: Abdel-Salam, Omar M.E., et al.
Publicado: (2010)

Spironolactone in cardiovascular disease: an expanding universe?
por: Funder, John W.
Publicado: (2017)

Imatinib and spironolactone suppress hepcidin expression
por: Mleczko-Sanecka, Katarzyna, et al.
Publicado: (2017)

Furosemide/spironolactone: Hypotension: case report
Publicado: (2022)

The effect of spironolactone on diastolic function in haemodialysis patients
por: Hauser, T., et al.
Publicado: (2021)

Spironolactone Reduces Severity of Obstructive Sleep Apnea in Patients with Resistant Hypertension: a Preliminary Report
por: Gaddam, Krishna, et al.
Publicado: (2009)

Clinical efficacy and safety of spironolactone in patients with resistant hypertension: A systematic review and meta-analysis
por: Chen, Cong, et al.
Publicado: (2020)

Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension
por: Tsujimoto, Tetsuro, et al.
Publicado: (2020)

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
por: Williams, Bryan, et al.
Publicado: (2018)

Impact of body mass index and diabetes on myocardial fat content, interstitial fibrosis and function
por: Dong, Xin, et al.
Publicado: (2022)

Advanced interstitial lung fibrosis with emphysema and pulmonary hypertension with no evidence for interstitial lung disease on high resolution CT
por: Foris, Vasile, et al.
Publicado: (2019)

DRESS Syndrome Secondary to Spironolactone with Atypical Presentation
por: Bains, Anupama, et al.
Publicado: (2020)

Therapeutic Efficacy of Spironolactone for Central Serous Chorioretinopathy
por: Han, Jae Yong, et al.
Publicado: (2022)

Interstitial fibrosis and growth factors.
por: Lasky, J A, et al.
Publicado: (2000)

Non-invasive assessment of interstitial myocardial fibrosis in pressure-overload left ventricular hypertrophy
por: Jabbour, Andrew, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g7b9dj2jqmq4l8l492frucovmo